Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01325207
Title	Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Northwestern University
Indications	Her2-receptor positive breast cancer
Therapies	Trastuzumab
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 8 of 8 entries

Facility	City	State	Zip	Country	Details
Columbia University	New York	New York	10032	United States	Details
Dana Farber Cancer Institute	Boston	Massachusetts	02215	United States	Details
Memorial Sloan-Kettering Cancer Center	New York	New York	10065	United States	Details
Northwestern University	Chicago	Illinois	60611	United States	Details
Rhode Island Hospital	Providence	Rhode Island	02903	United States	Details
Texas Oncology-Austin	Austin	Texas	78705	United States	Details
Tufts Medical Center	Boston	Massachusetts	02111	United States	Details
University of California San Francisco (UCSF)	San Francisco	California	94143-1710	United States	Details

Showing 1 to 8 of 8 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field